There seemed to be an association between the use of DPP-4 inhibitors and acute pancreatitis, although the number of randomised patients was not sufficient for a firm conclusion and the estimated risk of acute pancreatitis is small (one patient in 1066 patients treated with DPP-4 inhibitors). Here, DPP4 is linked to acute pancreatitis.